SuanNutra and a Portfolio Firm of Carbyne Equity Partners, broadens its Invention Range through Acquisitions of Specialty Natural Ingredients Productions from IFF

On July 21, 2026, SuanNutra enhances its position as a global leader in natural ingredients by acquiring IFF’s specialty divisions. This partnership offers science-based nutraceutical solutions, functional food ingredients, botanical extracts, and manufacturing capabilities by fueling research expertise across over 60 countries

SuanNutra focuses on becoming a global leader in innovative, research-driven natural solutions that respond to consumer and regulatory needs. SuanNutra, part of Carbyne Equity Partners, has acquired a portfolio of natural ingredients from IFF, thereby expanding its product capacity and market presence. The combined company of Monteloeder and Carbyne Equilty serves over 1,200 customers across 60 countries, with facilities in Spain, Peru, Slovenia, and the U.S., backup about 700 staff. For IFF, divestment refines its focus on core operations.

The agreement reflects industry consolidation influenced by demand for clean-label, plant-based, science-backed products. This aligns with SuanNutra’s Visible Health strategy, focused on clinically validated natural ingredients with measurable health benefits. It plans to invest in R&D, sustainable sourcing, and manufacturing while maintaining smooth customer service. This strengthens its market position with botanical extracts, fermented vitamins, antioxidants, flavors, and specialty ingredients for dietary supplements and foods.

Impact on the Nutraceuticals Industry

The global nutraceuticals market size was accounted at USD 626.19 billion in 2025 and predicted to increase from USD 672.29 billion in 2026 to approximately USD 1,102.94 billion by 2035, representing a CAGR of 5.82% from 2026 to 2035.

According to Precedence Research, as demand for evidence-based health products rises, suppliers with strong scientific backing are preferred. SuanNutra’s acquisition will significantly accelerate the nutraceutical industry by providing a diverse source of scientifically validated natural ingredients. Increased R&D target to develop new functional ingredients, while expanded manufacturing facilities in Europe, Latin America, and North America strengthen supply resilience.

Bigger companies may face increased competition, and the deal promotes higher standards in quality, compliance, traceability, and sustainability. The extended product range includes fermented vitamins, botanical extracts, antioxidants, minerals, and proprietary technologies, simplifying procurement and enhancing supply chain efficiency. Overall, it aligns with the industry's move toward integrated ingredient platforms, positioning SuanNutra as a main partner in preventive healthcare and personalized nutrition.

Impact on the Food Ingredients Industry

The global food ingredients market size is valued at USD 368.28 billion in 2025 and is predicted to increase from USD 385.96 billion in 2026 to approximately USD 588.56 billion by 2035, expanding at a CAGR of 4.80% over the forecast period from 2025 to 2035.

According to Precedence Research, manufacturers aim to improve taste, functionality, nutrition, and natural sourcing without compromising quality, aligning with consumer demand for clean-label products, transparency, and healthier solutions. The agreement benefits the global food and beverage ingredients sector as manufacturers adopt natural alternatives to synthetic additives. IFF’s specialty ingredients help SuanNutra expand its food enhancement solutions by stabilizing supply chains through diverse manufacturing facilities and raw material sources and ensuring continuity.

Rising competition is prompting investment in sustainable sourcing, advanced extraction, and product innovation in functional foods, including beverages, plant-based products, and dairy substitutes. The alliance encourages collaboration between ingredient suppliers and food manufacturers to develop customized, consumer-focused solutions. Overall, SuanNutra’s expanded capabilities support the industry's shift toward healthier, cleaner, and more functional foods with sophisticated supply chains and scientific backing.

Impact on the Natural Extracts Industry

The global natural extracts market size was estimated at USD 14.49 billion in 2025 and is predicted to increase from USD 15.86 billion in 2025 to approximately USD 31.66 billion by 2035, expanding at a CAGR of 8.13% from 2026 to 2035.

According to Precedence Research, this acquisition marks a major step for the natural ingredients and botanical extraction sector, creating a more integrated global supplier with expanded production and research. By adding botanical extraction and fermentation facilities, SuanNutra improves control over raw materials, processing, and quality. Vertical integration increases efficiency, sustainability, traceability, and uniformity, addressing increasing customer demand for transparency and standards. The deal reflects growing investor confidence in plant-based bioactives and natural compounds.

It reinforces a transition toward larger, research-driven, vertically integrated companies delivering quality, innovation, and value across markets. Increasing consumer interest in health, wellness, and sustainability is driving demand for premium natural ingredients, fueling substantial investment in advanced extraction, fermentation, innovation, and sustainable farming to stay competitive. The acquisition supports the development of standardized, clinically validated botanical ingredients that meet international regulatory requirements.

Expert Opinion

According to expert opinion, SuanNutra’s acquisition of IFF’s natural ingredients units enhances its competitive edge and expands its capabilities in research, manufacturing, innovation, and distribution. It also diversifies supply chains, reducing operational risks and building trust. The deal creates a diversified platform serving high-growth infrastructure in food, beverages, and wellness, aligned with demand for plant-based ingredients and science-based. Regulatory approvals and integration are crucial to achieve expected synergies.

For IFF, the acquisition refines its portfolio, allowing it to focus on core operations, and success depends on integration by maintaining quality. This move may accelerate industry consolidation, as companies seek larger portfolios and increased efficiency. Overall, the acquisition positions SuanNutra for sustained growth, supporting trends such as vertical integration, scientific validation, and sustainable sourcing.